Metraipolis › archive › dc_e4deeff1eab1

Prospective Phase II Trial of Biweekly Gemcitabine Plus Nab-Paclitaxel as First-Line Therapy in Patients Aged 75 Years and Older With Unresectable Pancreatic… — Europe PMC PMID:42735912

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42735912
DOI
10.1002/cnr2.70691
License (as archived)
solo-consultazione
Archived
2026-10-16T07:10:15.980Z
SHA-256 of the archived text
8b3a2a89695826c1ea1ec48a8e9ad84e2cec054b4d371cde3cd54a11b9787215
Stable URL of this page
https://metraipolis.com/documento/dc_e4deeff1eab1

How to cite

Prospective Phase II Trial of Biweekly Gemcitabine Plus Nab-Paclitaxel as First-Line Therapy in Patients Aged 75 Years and Older With Unresectable Pancreatic… — Europe PMC PMID:42735912 — Europe PMC (en), https://europepmc.org/article/MED/42735912 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_e4deeff1eab1 (Metraipolis archive dc_e4deeff1eab1, sha256 8b3a2a89695826c1ea1ec48a8e9ad84e2cec054b4d371cde3cd54a11b9787215)
BibTeX
@misc{dce4deeff1eab1,
  title = {Prospective Phase II Trial of Biweekly Gemcitabine Plus Nab-Paclitaxel as First-Line Therapy in Patients Aged 75 Years and Older With Unresectable Pancreatic… — Europe PMC PMID:42735912},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42735912},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_e4deeff1eab1; sha256 8b3a2a89695826c1ea1ec48a8e9ad84e2cec054b4d371cde3cd54a11b9787215},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42735912. Agents can read the archived copy with the MCP tool read_document.